News Articles

WBFO Interviews Dr. Janet Morrow

Monday, June 15th, 2020

Ferric Contrast Wins $750,000 NSF Grant

Wednesday, May 6th, 2020

Ferric Contrast has been awarded a National Science Foundation STTR Phase II grant for $750,000.  The grant will further commercialzation of our iron-based MRI contarst agents.

Ferric Contrast Goes to Washington

Tuesday, April 16th, 2019

Ferric Contrast Selected to Represent American Assocication of Universities  and Association of Public Land-Grant Universities at Capitol Hill Event

Ferric Contrast is a Semi-Finalist

Thursday, August 9th, 2018

FDA Safety Communication

Thursday, May 17th, 2018

Researchers Link Brain Tumors to Gadolinium Deposits

Tuesday, May 8th, 2018

Safety Issues Linger Over Gadolinium Based Contrast

Tuesday, April 24th, 2018

Ferric Contrast to Exhibit at Bright Buffalo Niagara

Tuesday, April 24th, 2018

Come by our booth May 2 at the historic Hotel Henry and see how we are making MRI imaging safer.

Ferric Contrast Awarded from Bruce Holm Fund

Monday, April 16th, 2018

Study Finds Gadolinium in Bone

Tuesday, March 27th, 2018

Canadian Researchers Find Residual MRI Contrast Agent in Tissue

Ferric Contrast Receives $225,000 NSF STTR Award

Tuesday, March 6th, 2018

Ferric Contrast, Inc.  wins competitive National Science Foundation STTR award to advance R&D on novel MRI contrast agents.

WBEN Buffalo Business Report

Wednesday, November 22nd, 2017

Ferric Contrast wins $50,000 at 2017 FuzeHub Commercialization Competition in Albany

Two UB startups win $50,000 in FuzeHub commercialization competition

Tuesday, November 21st, 2017

“This funding will help these companies advance their commercialization strategies, which was one of the major objectives of the competition.”
Elena Garuc, executive director